Thu, February 18, 2021

Doug Schenkel Maintained (TXG) at Buy with Increased Target to $200 on, Feb 18th, 2021

Doug Schenkel of Cowen & Co., Maintained "10x Genomics, Inc." (TXG) at Buy with Increased Target from $155 to $200 on, Feb 18th, 2021.

Doug has made no other calls on TXG in the last 4 months.



There are 2 other peers that have a rating on TXG. Out of the 2 peers that are also analyzing TXG, 1 agrees with Doug's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Amit Hazan of "Goldman Sachs" Initiated at Hold and Held Target at $150 on, Wednesday, December 2nd, 2020


This is the rating of the analyst that currently disagrees with Doug


  • Tejas Savant of "Morgan Stanley" Maintained at Buy with Increased Target to $145 on, Wednesday, November 11th, 2020